Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles

Ana Paula V. Castro, Técia M. U. Carvalho, Nissin Moussatché, Clarissa R. A. Damaso
Ana Paula V. Castro
1Laboratório de Biologia Molecular de Vírus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Técia M. U. Carvalho
2Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-590, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nissin Moussatché
1Laboratório de Biologia Molecular de Vírus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clarissa R. A. Damaso
1Laboratório de Biologia Molecular de Vírus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: damasoc@biof.ufrj.br
DOI: 10.1128/JVI.77.16.9052-9068.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Temporal synthesis and accumulation of CypA in VV-infected cells. BSC-40 cells were mock infected (NI) or infected with VV at 10 PFU/ml, and at the indicated times p.i., postnuclear cell extracts were prepared. (A) Proteins were resolved by SDS-13.5% PAGE, followed by Western blot analysis with anti-α-tubulin, anti-CypA, anti-F11L, and anti-A18R antibodies. (B, C, and D) At the indicated times p.i., the monolayers were pulse-labeled with [35S]methionine for 1 h, extracts were prepared, and 200-μg samples were loaded onto 8′A-Cs-Affi-Gel columns. The proteins retained by the resin were eluted with 2 mg of CsA per ml. Both the unbound (flowthrough) and eluted proteins were analyzed by SDS-13.5% PAGE and staining with Coomassie blue (B), followed by autoradiography (C and D). Asterisks indicate late VV proteins; H indicates a major host protein. CT refers to the control column unable to retain CypA. (E) At 2 h p.i., the monolayers were labeled with [35S]methionine (pulse; P) as described above and chased with medium containing unlabeled methionine for an additional 6 and 18 h. The extracts were prepared and loaded onto 8′A-Cs-Affi-Gel 10 columns as already described. The eluted proteins were resolved by SDS-PAGE and staining with Coomassie blue, followed by autoradiography. (F) The values obtained by densitometric analysis of the autoradiograms in panel E were corrected by the amount of eluted CypA obtained for the corresponding lane in the Coomassie blue-stained gels. The resulting ratio was calculated as described in Materials and Methods, and the final values are expressed as percentages of the 35S-labeled CypA synthesized at the time of the pulse (baseline). The values to the right of panel A and the left of panel B are molecular sizes in kilodaltons.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    (Top panels) Intracellular localization of CypA in VV-infected cells. BSC-40 cells were mock infected (NI) or infected with VV at 10 PFU/ml. At 20 h p.i., the cells were processed for confocal immunofluorescence microscopy with anti-CypA detected with a Cy3-conjugated secondary antibody (red channel; A and E). Viral and cellular DNAs were stained with DAPI (B and F). The merged images are shown in panels C and G. Phase-contrast images are shown in panels D and H. Arrows indicate redistribution of CypA to perinuclear regions of VV-infected cells. Asterisks indicate viral factories. Arrowheads point to colocalization of CypA with viral factories in the merged images. Representative fields are shown. N, nucleus; bar, 20 μm.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    (Bottom panels) Time course of CypA relocalization. BSC-40 cells were mock infected or infected with VV as described in Materials and Methods and harvested for immunofluorescence assay at the indicated times (A to L). In panels M to P, the cells were mock infected (P) or infected with VV (M, N, and O) and treated with 35 μM CsA at time zero. The infection proceeded for 12 h p.i., when the cells were processed for immunofluorescence assay. Anti-CypA labeling (red channel) is visualized in panels A, D, G, J, and M. Viral and cellular DNAs were stained with DAPI (blue channel), as shown in panels B, E, H, K, and N. Merged images are visualized in panels C, F, I, L, O, and P. White arrows indicate granular CypA structures in the cytoplasm. Thin arrows indicate the redistribution of CypA to perinuclear regions of VV-infected cells. Asterisks indicate viral factories. Arrowheads point to colocalization of CypA with viral factories in the merged images. Open arrows indicate CypA labeling outlining viral factories. Representative fields are shown. NI, mock-infected cells; N, nucleus; bars, 10 μm.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Distribution of CypA and α-tubulin in VV-infected cells. BSC-40 cells (A to E) and mouse embryo fibroblasts (F to H) were mock infected (A, B, and F) or infected with VV (C, D, E, G, and H) as described in Materials and Methods. At 20 h p.i., the monolayers were processed for immunofluorescence microscopy with anti-α-tubulin (A and C) and anti-CypA (B, D, F, and G) antibodies. Viral and cellular DNAs were stained with DAPI (E and H). Arrows indicate redistribution of CypA to perinuclear regions of VV-infected cells. Asterisks indicate viral factories. Representative fields are shown. N, nucleus; bars, 10 μm.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effects of metabolic inhibitors on the distribution of CypA. BSC-40 cells infected with VV were treated with 40 μg of AraC per ml for 10 h (A and B) or with 100 μg of CHX per ml for 6 h (E and F). Cells were processed for immunofluorescence microscopy with anti-CypA (A, C, and E) antibody. Viral and cellular DNAs were stained with DAPI (B, D, and F). (C and D) Untreated cells infected for 10 h. Thin arrows indicate granular CypA structures in the cytoplasm. White arrows indicate redistribution of CypA to perinuclear regions of VV-infected cells. Asterisks indicate viral factories. Representative fields are shown. N, nucleus; bars, 10 μm.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Localization of CypA in VV-infected cells in the absence of postreplicative protein synthesis. (A) Diagram of the assay. BSC-40 cells were infected with VV in the presence of 10 mM HU. At 6 h p.i. (B to D), the medium was replaced with HU-free medium in the absence (E to H) or presence (I to L) of 100 μg of CHX per ml. The cells were incubated for an additional 6 h and processed for immunofluorescence (IFM) with anti-CypA (B, E, and I) and anti-D8L (green channel; H and L) antibodies. Viral and cellular DNAs were stained with DAPI (C, F, and J). Merged images are shown in panels D, G, K, H, and L. Thin arrows indicate granular CypA structures in the cytoplasm. White arrows indicate redistribution of CypA to perinuclear regions of VV-infected cells. Asterisks indicate viral factories. Arrowheads point to colocalization of CypA with viral factories. Representative fields are shown. N, nucleus; bars, 10 μm.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Localization of CypA in ts53-infected cells. BSC-40 cells were infected with WT VV (A to H) or the VV mutant ts53 (I to T) at 31 or 40°C. After 12 h, the cells were processed for immunofluorescence microscopy with anti-CypA (A, E, I, M, and Q) and anti-D8L (green channel; D, H, L, P, and T) antibodies. Viral and cellular DNAs were stained with DAPI (B, F, J, N, and R). Merged images are shown in panels C, D, G, H, K, L, O, P, S, and T. In panels Q to T, ts53-infected cells were incubated for 12 h at 40°C and shifted to 31°C for 4 h, after which they were processed for immunofluorescence assay. White arrows indicate redistribution of CypA to perinuclear regions of VV-infected cells. Open arrows point to infected cells with no redistribution of CypA. Thin arrows point to redistribution of CypA to the periphery of the virosomes. Asterisks indicate viral factories. White arrowheads indicate colocalization of CypA with viral factories. Open arrowheads indicate the absence of colocalization of CypA with virosomes. Representative fields are shown. N, nucleus; bars, 10 μm.

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Localization of CypA in VV-infected cells by immunoelectron microscopy. BSC-40 cells mock infected (C) or infected with VV for 20 h were fixed and processed for immunogold labeling with anti-CypA antibody, followed by a colloidal gold-conjugated secondary antibody. Representative fields are shown. CypA labeling is indicated by arrows. In panels A, B, and D, note the intense labeling of amorphous electron-dense material in the proximity of VV particles. Arrowheads in panel E point to gold labeling in the periphery and within the viroplasm. In panels F to H, note the association of gold grains with the viroplasm being encapsidated by the crescent forms. CypA labeling is also found associated with electron-dense material and nucleoid of IVs (I and J). In mature particles, gold labeling is primarily found in the core (K to N). Cr, crescent forms; IVn, IVs with nucleoid; IEV, intracellular enveloped virus; N, nucleus.

  • FIG. 9.
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    Association of CypA with purified VV. Intracellular virus was sedimented on a sucrose cushion and banded on three successive sucrose gradients. Fractions were collected, and the number of particles was determined by OD measurement (A). Aliquots of each fraction were analyzed by SDS-PAGE, followed by a Western blot assay with antiserum raised against total VV proteins (B), anti-CypA (C), anti-α-tubulin, and anti-Hsp70 (C) antibodies. In lane CT, uninfected BSC-40 cell proteins were analyzed by Western blotting as a positive control for the anti-CypA, anti-α-tubulin, and anti-Hsp70 antibodies. Molecular size markers (kilodaltons) are shown to the left of panels B and C.

  • FIG. 10.
    • Open in new tab
    • Download powerpoint
    FIG. 10.

    Association of CypA with VV cores. (A and B) Purified VV (7.5 × 109 particles) was incubated with 0.5% NP-40 in the presence or absence of 50 mM DTT. The insoluble core fraction was recovered by centrifugation and treated with 0.2% deoxycholate (DOC). Insoluble and soluble fractions were obtained by centrifugation. The proteins were resolved by SDS-PAGE, followed by silver staining (A). The samples were also analyzed by Western blotting (B) with anti-CypA, anti-A18R, anti-D12R, anti-D1R, anti-A12L, and anti-H3L antibodies. T refers to untreated VV. I and S refer to insoluble and soluble fractions, respectively. (C) Purified VV (7.5 × 109 particles) was digested with different concentrations of proteinase K or with 50 μg of chymotrypsin per ml. The proteins in each sample were resolved by SDS-PAGE, followed by Western blot analysis with anti-CypA, anti-A18R, anti-D12R, anti-D8L, and anti-H3L antibodies. The values to the left of panel A are molecular sizes in kilodaltons.

  • FIG. 11.
    • Open in new tab
    • Download powerpoint
    FIG. 11.

    Detection of CypA in purified VV by immunogold labeling and negative staining. Purified VV (1.5 × 108 particles) was adsorbed to Formvar-coated nickel grids and left unpermeabilized (A, C, E, and F) or permeabilized with Triton X-100 (B and G) or NP-40-DTT (D). The grids were incubated separately with anti-CypA (A to D), anti-D8L, anti-H3L (E), or anti-D12R (F and G) antibody, followed by a colloidal gold-conjugated secondary antibody. Representative fields are shown.

Tables

  • Figures
  • TABLE 1.

    Colocalization of CypA with viral factories in cells infected with VV mutant ts53a

    Virus (temp °C)12 h p.i.Shiftdown to 31°C
    2 h4 h
    No. of cellsColocalization (%)No. of cellsColocalization (%)No. of cellsColocalization (%)
    WT (31)396349 (88.1)
    WT (40)224165 (73.7)
    ts53 (31)234176 (75.2)
    ts53 (40)37372 (19.3)249120 (48.2)305242 (79.3)
    • ↵ a BSC-40 cells were infected with WT VV or ts53 (MOI = 5) at both 31 and 40°C and harvested at 12 h p.i. for immunofluorescence microscopy. A sample of cells infected with ts53 at 40°C for 12 h was shifted to 31°C for an additional 2 or 4 h. The cells in more than 40 random fields were counted.

PreviousNext
Back to top
Download PDF
Citation Tools
Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles
Ana Paula V. Castro, Técia M. U. Carvalho, Nissin Moussatché, Clarissa R. A. Damaso
Journal of Virology Jul 2003, 77 (16) 9052-9068; DOI: 10.1128/JVI.77.16.9052-9068.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles
Ana Paula V. Castro, Técia M. U. Carvalho, Nissin Moussatché, Clarissa R. A. Damaso
Journal of Virology Jul 2003, 77 (16) 9052-9068; DOI: 10.1128/JVI.77.16.9052-9068.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

cyclophilin A
vaccinia
vaccinia virus
virion

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514